MEDICINES CO /DE 4

Accession 0001179110-14-001313

CIK 0001113481operating

View on SEC.gov Company Profile

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 5:01 PM ET

Size

21.0 KB

Accession

0001179110-14-001313

Insider Transaction Report

Form 4

Period: 2014-01-21

MEDICINES CO /DEMDCO

Antinori Paul Michael

SVP and General Counsel

Transactions

Exercise/Conversion
Common Stock
2014-01-21$7.31/sh+10,500$76,755→ 41,912 total
Sale
Common Stock
2014-01-21$38.09/sh−20,000$761,814→ 31,412 total
Sale
Common Stock
2014-01-21$37.82/sh−7,000$264,720→ 31,412 total
Exercise/Conversion
Stock Option (right-to-buy)
2014-01-21−10,500→ 2,000 total
Exercise: $7.31Exp: 2020-02-19→ Common Stock (10,500 underlying)
Sale
Common Stock
2014-01-21$38.00/sh−10,500$399,025→ 31,412 total
Exercise/Conversion
Common Stock
2014-01-21$14.82/sh+20,000$296,400→ 51,412 total
Exercise/Conversion
Common Stock
2014-01-21$17.45/sh+7,000$122,150→ 38,412 total
Sale
Common Stock
2014-01-21$38.05/sh−383$14,574→ 31,029 total
Exercise/Conversion
Stock Option (right-to-buy)
2014-01-21−7,000→ 6,333 total
Exercise: $17.45Exp: 2021-02-18→ Common Stock (7,000 underlying)
Exercise/Conversion
Stock Option (right-to-buy)
2014-01-21−20,000→ 8,330 total
Exercise: $14.82Exp: 2020-09-17→ Common Stock (20,000 underlying)

Footnotes (9)

[F1]The common stock sales were effected pursuant to a Rule 10b5-1 program adopted by the reporting person on December 13, 2013.
[F2]Represents the weighted average sales price of the shares sold ranging from a low of $37.77 to a high of $38.31 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F3]Represents the weighted average sales price of the shares sold ranging from a low of $37.72 to a high of $38.46 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F4]Represents the weighted average sales price of the shares sold ranging from a low of $37.70 to a high of $38.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F5]Represents the weighted average sales price of the shares sold ranging from a low of $38.05 to a high of $38.06 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
[F6]This option vests in forty-eight equal monthly installments beginning on March 19, 2010.
[F7]This option vests in forty-eight equal monthly installments beginning October 17, 2010.
[F8]This option vests in forty-eight equal monthly installments beginning on March 18, 2011.
[F9]Not applicable.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

MEDICINES CO /DE

CIK 0001113481

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0001113481

Filing Metadata

Form type: 4
Filed: Jan 22, 7:00 PM ET
Accepted: Jan 23, 5:01 PM ET
Size: 21.0 KB

View on SEC.gov